Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Axonics Modulation Technologies, Inc. operates as a medical technology company. The Company focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation solutions which used to treat patients with overactive bladder, fecal incontinence, andurinary retention. Axonics Modulation Technologies serves patients globally.
Website: axonics.com



Growth: Good revenue growth rate 24.7%, there is slowdown compared to average historical growth rates 31.2%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is positive, +0.6%. On average the margin is decreasing steadily. Gross margin is high, +77.2%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.14 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -1.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 47.9% higher than minimum and 0.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.0x by EV / Sales multiple , the company can be 65.7% overvalued

Key Financials (Download financials)

Ticker: AXNX
Share price, USD:  (0.0%)70.98
year average price 70.98  


year start price 70.98 2025-01-22

max close price 70.98 2025-01-22

min close price 70.98 2025-01-22

current price 70.98 2026-01-21
Common stocks: 45 238 201

Dividend Yield:  0.0%
FCF Yield LTM: -1.3%
EV / LTM EBITDA: 1 502.0x
EV / Sales: 8.8x
Margin (EBITDA LTM / Revenue): 0.6%
Fundamental value created in LTM:
Market Cap ($m): 3 211
Net Debt ($m): -207
EV (Enterprise Value): 3 004
Price to Book: 4.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-11-19zacks.com

Boston Scientific Stock Set to Gain From Completion of Axonics Deal

2024-11-15prnewswire.com

Boston Scientific Closes Acquisition of Axonics, Inc.

2024-11-07zacks.com

Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates

2024-09-27zacks.com

Axonics Shares Fall Despite Australia's Approval for R20 SNM Device

2024-09-25zacks.com

Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic

2024-08-01zacks.com

Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates

2024-03-29Zacks Investment Research

All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy

2024-03-15Zacks Investment Research

Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System

2024-02-28Zacks Investment Research

Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass Estimates

2024-01-31Zacks Investment Research

4 Stocks Backed by High Efficiency to Enrich Your Portfolio
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-11-07 2024-08-01 2024-04-30 2023-10-31 2023-07-31 2023-05-02 2022-11-09
acceptedDate 2024-11-07 16:08:53 2024-08-01 16:07:02 2024-04-30 16:28:58 2024-04-29 16:39:05 2023-10-30 18:17:07 2023-07-31 17:23:01 2023-05-01 21:01:02 2023-03-01 16:24:17 2022-11-09 16:07:51 2022-03-01 17:21:54 2021-03-01 16:55:05 2020-03-04 16:31:31
calendarYear 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
revenue 116M 115M 91M 366M 93M 23M 71M 274M 70M 180M 112M 14M
costOfRevenue 27M 28M 22M 92M 24M 23M 18M 76M 19M 65M 44M 6M
grossProfit 90M 87M 69M 275M 69M 0 53M 198M 51M 116M 67M 7M
grossProfitRatio 0.772 0.758 0.758 0.742 0 0.743 0.728
researchAndDevelopmentExpenses 13M 13M 11M 35M 8M 9M 8M 34M 8M 37M 29M 20M
generalAndAdministrativeExpenses 24M 16M 15M 46M 12M 11M 12M 40M 9M 33M 26M 19M
sellingAndMarketingExpenses 53M 51M 56M 190M 48M 44M 43M 156M 40M 106M 66M 49M
sellingGeneralAndAdministrativeExpenses 77M 68M 71M 235M 59M 55M 55M 196M 49M 139M 92M 68M
otherExpenses 6M 0 0 15M 0 0 2M 9M 2M 7M -412 150 0
operatingExpenses 90M 81M 85M 270M 70M 66M 65M 240M 59M 183M 121M 88M
costAndExpenses 122M 108M 107M 392M 94M 23M 83M 316M 79M 248M 165M 94M
interestIncome 5M 5M 4M 17M 4M 4M 4M 5M 2M 40 000 761 000 3M
interestExpense 0 32 000 59 000 0 83 000 174 000 683 000 2M 2M 7M 2M 2M
depreciationAndAmortization 3M 3M 4M 12M 2M 2M 4M 13M -4M 10M 3M 2M
ebitda 421 000 10M -8M 8M 6M 22M -9M -47M -13M -62M -51M -78M
ebitdaratio 0.004 0.085 -0.09 0.063 0.983 -0.122 -0.178
operatingIncome -6M 6M -19M -26M -687 000 20M -13M -42M -8M -67M -54M -81M
operatingIncomeRatio -0.054 0.055 -0.21 -0.007 0.882 -0.178 -0.116
totalOtherIncomeExpensesNet 5M 5M -4M 17M 4M -16M 3M 3M -9M -7M -1M 665 000
incomeBeforeTax -2M 8M -15M -9M 4M -8M -10M -62M -17M -79M -55M -80M
incomeBeforeTaxRatio -0.013 0.073 -0.167 0.038 -0.337 -0.142 -0.238
incomeTaxExpense -2M 1M 4M -3M -427 000 -8M -807 000 -3M -520 000 782 000 1000 1000
netIncome -21 000 7M -19M -6M 4M -7M -9M -60M -16M -80M -55M -80M
netIncomeRatio -0 0.06 -0.209 0.042 -0.323 -0.131 -0.231
eps -0 0.13 -0.38 -0.12 0.078 -0.15 -0.19 -1.28 -0.34 -1.86 -1.48 -2.8
epsdiluted -0 0.13 -0.38 0.078 -0.15 -0.19 -0.34
weightedAverageShsOut 51M 51M 51M 49M 50M 49M 49M 47M 47M 43M 37M 29M
weightedAverageShsOutDil 51M 51M 51M 49M 50M 49M 49M 47M 47M 43M 37M 29M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-04-29 2023-03-01 2022-03-01 2021-03-01 2020-03-04
fiscalYear 2023 2022 2021 2020 2019
netInterestIncome 17M 3M -7M -1M 665 000
ebit -5M -60M -72M -53M -78M
nonOperatingIncomeExcludingInterest -21M -5M 51 000 -720 000 -3M
netIncomeFromContinuingOperations -6M -60M -80M -55M -80M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -6M -60M -80M -55M -80M
epsDiluted -0.12 -1.28 -1.86 -1.48 -2.8

Balance Sheet Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-11-07 2024-08-01 2024-04-30 2023-10-31 2023-07-31 2023-05-02 2022-11-09
acceptedDate 2024-11-07 16:08:53 2024-08-01 16:07:02 2024-04-30 16:28:58 2024-04-29 16:39:05 2023-10-30 18:17:07 2023-07-31 17:23:01 2023-05-01 21:01:02 2023-03-01 16:24:17 2022-11-09 16:07:51 2022-03-01 17:21:54 2021-03-01 16:55:05 2020-03-04 16:31:31
calendarYear 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
cashAndCashEquivalents 239M 169M 233M 105M 147M -3M 240M 239M 241M 221M 241M 171M
shortTermInvestments 106M 175M 100M 240M 197M 186M 117M 118M 109M 0 0 13M
cashAndShortTermInvestments 345M 343M 333M 345M 345M 332M 357M 357M 350M 221M 241M 184M
netReceivables 63M 57M 51M 57M 49M 47M 40M 45M 37M 29M 18M 8M
inventory 114M 105M 93M 80M 75M 70M 66M 56M 58M 65M 63M 16M
otherCurrentAssets 4M 6M 6M 9M 7M 6M 6M 7M 5M 6M 5M 4M
totalCurrentAssets 526M 512M 482M 491M 475M 455M 470M 465M 449M 321M 328M 212M
propertyPlantEquipmentNet 21M 40M 17M 33M 7M 6M 7M 7M 7M 7M 6M 3M
goodwill 105M 99M 99M 99M 95M 99M 97M 94M 87M 106M 0 0
intangibleAssets 78M 76M 78M 81M 80M 86M 86M 86M 82M 106M 196 000 311 000
goodwillAndIntangibleAssets 183M 175M 177M 181M 176M 99M 182M 181M 169M 212M 196 000 311 000
longTermInvestments 0 19M 16M 0 0 0 0 0 0 0 0 0
taxAssets 0 0 -16M 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 45M 2M 40M 14M 3M -4M 7M 7M 7M 8M 8M 5M
totalNonCurrentAssets 248M 235M 234M 229M 185M 102M 196M 194M 183M 227M 14M 8M
otherAssets 0 0 0 0 0 92M 0 0 0 0 0 0
totalAssets 774M 747M 716M 720M 661M 649M 666M 659M 632M 548M 342M 220M
accountPayables 20M 19M 16M 18M 15M 12M 15M 9M 10M 8M 11M 6M
shortTermDebt 3M 2M 1M 2M 2M 2M 2M 2M 2M 1M 22M 602 000
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 0 0 0 0 0
otherCurrentLiabilities 42M 36M 31M 13M 19M 18M 50M 38M 49M 11M 5M 3M
totalCurrentLiabilities 64M 57M 48M 46M 36M 32M 66M 65M 61M 27M 46M 12M
longTermDebt 30M 30M 30M 0 876 000 1M 7M 0 8M 0 0 20M
deferredRevenueNonCurrent 0 0 -10M 0 -14M -14M 0 -16M 0 0 0 0
deferredTaxLiabilitiesNonCurrent 15M 16M 10M 11M 14M 15M 16M 16M 14M 19M 0 0
otherNonCurrentLiabilities 0 0 10M 0 14M -1M 0 16M 10M 10M 0 0
totalNonCurrentLiabilities 45M 47M 40M 37M 15M 1M 23M 24M 22M 39M 9M 25M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 33M 32M 32M 28M 3M 3M 9M 9M 9M 10M 10M 5M
totalLiabilities 110M 104M 88M 82M 50M 33M 89M 89M 83M 66M 55M 37M
preferredStock 0 0 0 0 0 373M 0 0 0 0 0 0
commonStock 5000 5000 5000 5000 5000 5000 5000 5000 5000 5000 4000 3000
retainedEarnings -393M -393M -399M -380M -387M -391M -384M -374M -375M -315M -234M -180M
accumulatedOtherComprehensiveIncomeLoss -6M -17M -17M -16M -25M -18M -22M -25M -36M -7M -431 000 -428 000
othertotalStockholdersEquity 1 063M 1 052M 1 044M 1 022M 18M 982M 961M
totalStockholdersEquity 664M 643M 627M 638M 611M -18M 577M 570M 550M 482M 287M 183M
totalEquity 664M 643M 627M 638M 611M -18M 577M 570M 550M 482M 287M 183M
totalLiabilitiesAndStockholdersEquity 774M 747M 716M 661M 649M 666M 632M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 774M 747M 716M 720M 661M 649M 666M 659M 632M 548M 342M 220M
totalInvestments 106M 193M 100M 240M 197M 186M 117M 118M 109M 0 0 13M
totalDebt 33M 32M 32M 28M 3M 3M 9M 9M 9M 10M 33M 25M
netDebt -207M -136M -201M -77M -144M 6M -231M -230M -232M -210M -208M -146M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-04-29 2023-03-01 2022-03-01 2021-03-01 2020-03-04
fiscalYear 2023 2022 2021 2020 2019
accountsReceivables 57M 45M 29M 18M 8M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 18M 9M 8M 11M 6M
otherPayables 0 0 0 0 0
accruedExpenses 11M 15M 5M 6M 2M
capitalLeaseObligationsCurrent 2M 2M 1M 1M 602 000
capitalLeaseObligationsNonCurrent 26M 8M 9M 9M 4M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 034M 970M 804M 522M 363M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4 2019 q4
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31 2019-12-31
symbol AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX AXNX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-11-07 2024-08-01 2024-04-30 2023-10-31 2023-07-31 2023-05-02 2022-11-09
acceptedDate 2024-11-07 16:08:53 2024-08-01 16:07:02 2024-04-30 16:28:58 2024-04-29 16:39:05 2023-10-30 18:17:07 2023-07-31 17:23:01 2023-05-01 21:01:02 2023-03-01 16:24:17 2022-11-09 16:07:51 2022-03-01 17:21:54 2021-03-01 16:55:05 2020-03-04 16:31:31
calendarYear 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY FY
netIncome -21 000 7M -19M -6M 4M -7M -9M -60M -16M -80M -55M -80M
depreciationAndAmortization 3M 3M 3M 13M 3M 3M 3M 12M 3M 9M 2M 1M
deferredIncomeTax -2M 8M -2M -7M -988 000 -516 000 -1M -184 000 8000 582 000 431 000 75 000
stockBasedCompensation 8M 9M 10M 45M 11M 11M 11M 32M 8M 25M 15M 9M
changeInWorkingCapital -9M -12M -3M -66M -5M -42M -6M -3M 9M -10M -47M -14M
accountsReceivables -5M -7M 6M -12M -2M -7M 5M -16M -960 000 -9M -11M -8M
inventory -8M -15M -14M -26M -5M -4M -10M 8M 36 000 -1M -47M -12M
accountsPayables 675 000 4M -3M 9M 3M -3M 6M 1M 364 000 -3M 5M 2M
otherWorkingCapital 4M 6M 1M -37M -1M -28M -6M 3M 10M 3M 6M 3M
otherNonCashItems 708 000 36M 1M 19M 13 000 16M 2M 22M -8000 8M 939 000 873 000
netCashProvidedByOperatingActivities 922 000 17M -9M -2M 12M -19M -781 000 3M 4M -47M -84M -83M
investmentsInPropertyPlantAndEquipment -3M -1M -3M -4M -1M -256 000 -794 000 -2M -963 000 -2M -3M -1M
acquisitionsNet 0 0 0 0 10M 68M 0 56M 0 -141M 0 -47M
purchasesOfInvestments -69M -143M -28M -427M -114M -122M -52M -175M -118M 0 0 -36M
salesMaturitiesOfInvestments 143M 67M 169M 313M 104M 54M 54M 57M 20M 0 13M 83M
otherInvestingActivites 0 -76M 141M -10M -68M 0 0
netCashUsedForInvestingActivites 70M -77M 138M -11M -69M 694 000 -99M
debtRepayment 0 0 0 0 0 0 0
commonStockIssued -489 000 241 000 248 000 878 000 864 000 2M 128M
commonStockRepurchased 0 0 0 15M 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites 3M 241 000 248 000 878 000 -8M 0 3M
netCashUsedProvidedByFinancingActivities 3M 241 000 248 000 878 000 -7M 2M 132M
effectOfForexChangesOnCash 710 000 -1M 2M 979 000 -189 000 -164 000 -584 000 1M 2M -508 000 -3000 -12 000
netChangeInCash 93M -64M 131M -121M 2M -95M 1M 18M 38M -20M 70M 73M
cashAtEndOfPeriod 262M 169M 248M 118M 147M 145M 240M 239M 241M 221M 241M 171M
cashAtBeginningOfPeriod 169M 233M 118M 239M 145M 240M 239M 221M 203M 241M 171M 98M
operatingCashFlow 922 000 17M -9M -2M 12M -19M -781 000 3M 4M -47M -84M -83M
capitalExpenditure -3M -1M -3M -4M -1M -256 000 -794 000 -2M -963 000 -2M -3M -1M
freeCashFlow -2M 16M -12M -6M 11M -19M -2M 968 000 3M -50M -87M -85M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-04-29 2023-03-01 2022-03-01 2021-03-01 2020-03-04
fiscalYear 2023 2022 2021 2020 2019
otherInvestingActivities 0 -56M 0 13M 47M
netCashProvidedByInvestingActivities -117M -120M -143M 10M 45M
netDebtIssuance 0 0 -26M 0 0
longTermNetDebtIssuance 0 0 -26M 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 128M 201M 150M 118M
netCommonStockIssuance 0 128M 201M 150M 118M
commonStockIssuance 4M 128M 201M 150M 118M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -3M 5M -5M -5M -7M
netCashProvidedByFinancingActivities -3M 134M 171M 144M 111M
incomeTaxesPaid 255 000 667 000 1000 1000 1000
interestPaid 69 000 1000 2M 1M 1M

Earning call transcript

2023 q3
2023-10-30 ET (fiscal 2023 q3)
2023 q2
2023-07-27 ET (fiscal 2023 q2)
2023 q1
2023-05-01 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-01 ET (fiscal 2022 q2)
2022 q1
2022-05-08 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2024-11-07 16:08 ET
Axonics Modulation Technologie reported for 2024 q3
SEC form 8
2024-11-07 16:03 ET
Axonics Modulation Technologie reported for 2024 q3
SEC form 8
2024-11-07 16:03 ET
Axonics Modulation Technologie published news for 2024 q3
SEC form 10
2024-08-01 16:07 ET
Axonics Modulation Technologie published news for 2024 q2
SEC form 8
2024-08-01 00:00 ET
Axonics Modulation Technologie published news for 2024 q2
SEC form 8
2024-08-01 00:00 ET
Axonics Modulation Technologie published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Axonics Modulation Technologie reported for 2024 q2
SEC form 10
2024-04-30 16:28 ET
Axonics Modulation Technologie published news for 2024 q1
SEC form 8
2024-04-30 16:09 ET
Axonics Modulation Technologie reported for 2024 q1
SEC form 8
2024-04-30 16:09 ET
Axonics Modulation Technologie published news for 2024 q1
SEC form 10
2024-04-30 00:00 ET
Axonics Modulation Technologie published news for 2024 q1
SEC form 10
2024-02-29 00:00 ET
Axonics Modulation Technologie published news for 2023 q4
SEC form 10
2024-02-28 20:36 ET
Axonics Modulation Technologie published news for 2023 q4
SEC form 8
2024-02-28 16:05 ET
Axonics Modulation Technologie published news for 2023 q4
SEC form 8
2024-02-28 16:05 ET
Axonics Modulation Technologie reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Axonics Modulation Technologie published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Axonics Modulation Technologie published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Axonics Modulation Technologie published news for 2023 q4
SEC form 10
2023-10-31 00:00 ET
Axonics Modulation Technologie published news for 2023 q3
SEC form 10
2023-10-30 18:17 ET
Axonics Modulation Technologie published news for 2023 q3
SEC form 8
2023-10-30 16:06 ET
Axonics Modulation Technologie reported for 2023 q3
SEC form 10
2023-07-31 00:00 ET
Axonics Modulation Technologie published news for 2023 q2
SEC form 6
2023-07-27 16:05 ET
Axonics Modulation Technologie reported for 2023 q2
SEC form 8
2023-07-27 00:00 ET
Axonics Modulation Technologie published news for 2023 q2
SEC form 6
2023-06-27 16:06 ET
Axonics Modulation Technologie published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
Axonics Modulation Technologie published news for 2023 q1
SEC form 8
2023-05-01 00:00 ET
Axonics Modulation Technologie published news for 2023 q1
SEC form 8
2023-03-01 00:00 ET
Axonics Modulation Technologie reported for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Axonics Modulation Technologie reported for 2022 q4
SEC form 8
2023-01-11 00:00 ET
Axonics Modulation Technologie published news for 2022 q4
SEC form 10
2022-11-09 00:00 ET
Axonics Modulation Technologie reported for 2022 q3
SEC form 8
2022-10-31 00:00 ET
Axonics Modulation Technologie reported for 2022 q3
SEC form 8
2022-08-01 00:00 ET
Axonics Modulation Technologie reported for 2022 q2
SEC form 10
2022-08-01 00:00 ET
Axonics Modulation Technologie reported for 2022 q2
SEC form 8
2022-05-05 00:00 ET
Axonics Modulation Technologie reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Axonics Modulation Technologie reported for 2022 q1
SEC form 10
2022-03-01 00:00 ET
Axonics Modulation Technologie published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Axonics Modulation Technologie published news for 2021 q4
SEC form 8
2022-01-06 00:00 ET
Axonics Modulation Technologie published news for 2021 q4
SEC form 8
2021-11-04 00:00 ET
Axonics Modulation Technologie published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Axonics Modulation Technologie published news for 2021 q3
SEC form 8
2021-08-05 00:00 ET
Axonics Modulation Technologie published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Axonics Modulation Technologie published news for 2021 q2
SEC form 8
2021-05-06 00:00 ET
Axonics Modulation Technologie published news for 2021 q1